Found 4 matching trials
Phase II Study of Folotyn With Leucovorin to Prevent/Reduce Mucositis in Patients With Hematological Malignancies
PHASE2This study is to evaluate the effect of leucovorin in preventing or reducin...
Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn
PHASE1The purpose of this study is determine the optimal dose and schedule of Fus...
Location
Multiple Locations
Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma
PHASE1This is an open-label, Phase 1/2a, dose-finding study with an initial phase...
Location
University of Virginia
Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®
PHASE1To determine the optimal dose and schedule of Fusilev to prevent or reduce ...
Location
Multiple Locations